Company intelligence / Profile preview

Bioplus Life Sciences

Bangalore, Karnataka, Indiabioplus.in ↗

Ownership: Private
Employees: ~750
Development stage: Preclinical

Overview

Two lead programs are Phase III ready for large unmet needs. Notable recent clinical data presented for pediatric myopia program "7-MX" showing high efficacy in children. EFSA approval secured for algal DHA use in infant formula.[2]

Therapeutic areas: GastroenterologyCardiovascularOphthalmologyWomen's Health
Modalities: Small molecules[1][4]Nutraceuticals/functional ingredients[3][4][9]Microbial fermentation products[4][5]Peptides & proteins[1]
Industry: Biotech

Partnerships

Focused on building global partnerships regionally/globally to optimize market access; specifics not disclosed but active outlicensing of generics to EU/ROW partners noted.[1][4][5]

Beyond the preview

Go deeper on Bioplus Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bioplus Life Sciences.

Explore the full profile